Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1994-11-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0038-3317
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
233-4
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:7939576-Anticoagulants,
pubmed-meshheading:7939576-Aspirin,
pubmed-meshheading:7939576-Atrial Fibrillation,
pubmed-meshheading:7939576-Cerebrovascular Disorders,
pubmed-meshheading:7939576-Clinical Trials as Topic,
pubmed-meshheading:7939576-Humans,
pubmed-meshheading:7939576-Prothrombin Time,
pubmed-meshheading:7939576-Risk Factors,
pubmed-meshheading:7939576-Warfarin
|
pubmed:year |
1994
|
pubmed:articleTitle |
Anticoagulation update.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|